Compounds > telmisartan
Page last updated: 2024-08-24

telmisartan and Fatty Liver, Nonalcoholic

telmisartan has been researched along with Fatty Liver, Nonalcoholic in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (64.29)24.3611
2020's5 (35.71)2.80

Authors

AuthorsStudies
Alexopoulos, SJ; Chen, SY; Childress, ES; Dai, Y; Garcia, CJ; Hargett, SR; Hoehn, KL; Salamoun, JM; Santiago-Rivera, J; Santos, WL; Shah, DP; Tucker, SP1
Alexopoulos, SJ; Beretta, M; Chen, SY; Garcia, CJ; Hargett, SR; Hoehn, KL; Murray, JH; Olzomer, EM; Salamoun, JM; Santos, WL; Shah, DP; Tucker, SP1
Al-Nimer, MSM; Mohammed, MO; Wasta Esmail, VA1
Abraham, SJK; Dedeepiya, VD; Ikewaki, N; Iwasaki, M; Levy, GA; Preethy, S; Raghavan, K; Ranganathan, N; Senthilkumar, R; Srinivasan, S; Yamamoto, N1
Devan, AR; Kumar, AR; Nair, B; Nath, LR1
Borém, LMA; Brandi, IV; Lelis, DF; Neto, JFR; Santos, SHS1
Choi, CS; Han, YI; Kang, KW; Mok, JS; Park, HD; Park, J; Park, JG; Park, TS1
Ali, RA; Alqarni, I; Badr, AM; Bassiouni, YA1
Cynis, H; Demuth, HU; Fujii, M; Haegele, M; Heiser, U; Hoffmann, T; Kehlen, A; Schilling, S; Shibazaki, Y; Yoneyama, H1
Liu, Y; Wang, B; Wang, Q; Wang, X; Wang, Y; Yang, Q; Zhang, C; Zhang, Q1
Chen, PP; Hu, ZB; Liu, BC; Liu, L; Lu, J; Ma, KL; Ruan, XZ; Wang, GH; Wen, Y; Wu, Y; Zhang, Y1
Breitbart, E; Ishai, E; Mendel, I; Shoham, A; Yacov, N1
Fujisawa, K; Kuwashiro, S; Matsumoto, T; Nishina, H; Oishi, T; Sakaida, I; Terai, S1
Aso, K; Haneda, M; Kanamori, H; Makino, Y; Nakade, Y; Nakao, H; Ohashi, T; Okada, M; Sato, K; Tamaki, Y; Yamauchi, T; Yokohama, S; Yoneda, M1

Reviews

2 review(s) available for telmisartan and Fatty Liver, Nonalcoholic

ArticleYear
An insight into the role of telmisartan as PPAR-γ/α dual activator in the management of nonalcoholic fatty liver disease.
    Biotechnology and applied biochemistry, 2022, Volume: 69, Issue:2

    Topics: Humans; Liver; Non-alcoholic Fatty Liver Disease; PPAR alpha; PPAR gamma; Telmisartan

2022
The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2018, Volume: 41, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Renin-Angiotensin System; Telmisartan

2018

Trials

1 trial(s) available for telmisartan and Fatty Liver, Nonalcoholic

ArticleYear
Effects of Orlistat or Telmisartan on the Serum Free Fatty Acids in Non-alcoholic Fatty Liver Disease Patients: An Open-Labeled Randomized Controlled Study.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2022, Volume: 33, Issue:5

    Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Humans; Non-alcoholic Fatty Liver Disease; Orlistat; Telmisartan; Triglycerides

2022

Other Studies

11 other study(ies) available for telmisartan and Fatty Liver, Nonalcoholic

ArticleYear
[1,2,5]Oxadiazolo[3,4-
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Animals; Diamines; Liver; Male; Mice, Inbred C57BL; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Oxadiazoles; Oxygen Consumption; Pyrazines; Uncoupling Agents

2020
6-Amino[1,2,5]oxadiazolo[3,4-
    Journal of medicinal chemistry, 2020, 06-11, Volume: 63, Issue:11

    Topics: Alanine Transaminase; Aniline Compounds; Animals; Cell Line; Diet, High-Fat; Disease Models, Animal; Half-Life; Liver; Mice; Mitochondria; Myoblasts; Non-alcoholic Fatty Liver Disease; Oxygen Consumption; Pyrazines; Rats; Structure-Activity Relationship; Triglycerides; Uncoupling Protein 1

2020
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease.
    BMJ open gastroenterology, 2022, Volume: 9, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Firmicutes; Fructose; Gastrointestinal Microbiome; Glucans; Humans; Isoleucine; Leucine; Metabolome; Mice; Non-alcoholic Fatty Liver Disease; Ornithine; RNA, Ribosomal, 16S; Spermidine; Succinic Acid; Telmisartan; Tryptophan; Water

2022
Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan.
    Scientific reports, 2019, 03-08, Volume: 9, Issue:1

    Topics: Angiotensins; Animals; Cell Line, Tumor; Inflammation; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Telmisartan; Transcriptome

2019
Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors.
    Biochemical pharmacology, 2019, Volume: 164

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Chlorogenic Acid; Drug Therapy, Combination; Fructose; Lysophospholipids; Male; Non-alcoholic Fatty Liver Disease; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Wistar; Signal Transduction; Sphingosine; Telmisartan; Toll-Like Receptor 4

2019
Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.
    International journal of experimental pathology, 2013, Volume: 94, Issue:3

    Topics: Aminoacyltransferases; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Line, Tumor; Chemokine CCL2; Disease Models, Animal; Enzyme Inhibitors; Fatty Liver; Hepatitis; Human Umbilical Vein Endothelial Cells; Humans; Leukemia, Monocytic, Acute; Macrophages; Mice; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Telmisartan

2013
[Effects of telmisartan on resistin expression in a rat model of nonalcoholic steatohepatitis and insulin resistance].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:4

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzimidazoles; Benzoates; Cholesterol; Diet, High-Fat; Disease Models, Animal; Insulin; Insulin Resistance; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Resistin; Telmisartan; Triglycerides

2015
Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:10

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Cholesterol; Diet, High-Fat; Dyslipidemias; Extracellular Matrix; Hep G2 Cells; Humans; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Receptor, Angiotensin, Type 1; Receptors, LDL; Renin-Angiotensin System; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Telmisartan

2016
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:9

    Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blotting, Western; Cell Movement; Cytokines; Dendritic Cells; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glycerophosphates; Glycerylphosphorylcholine; Hepatic Stellate Cells; Humans; Inflammation; Kupffer Cells; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Phospholipids; Pyridinium Compounds; Real-Time Polymerase Chain Reaction; Telmisartan; Toll-Like Receptor 2; Toll-Like Receptor 4; Triglycerides

2016
Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation.
    Cell and tissue research, 2011, Volume: 344, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Carnitine O-Palmitoyltransferase; Cell Movement; Disease Models, Animal; Fats; Fatty Liver; Gene Expression; Humans; Macrophages; Non-alcoholic Fatty Liver Disease; Oryzias; Oxidative Stress; PPAR gamma; Telmisartan; Weight Gain

2011
Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.
    Journal of gastroenterology, 2013, Volume: 48, Issue:4

    Topics: Amino Acids; Angiotensin II Type 1 Receptor Blockers; Animals; Anticarcinogenic Agents; Benzimidazoles; Benzoates; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Choline Deficiency; Diet; Drug Evaluation, Preclinical; Fatty Liver; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Cirrhosis; Liver Neoplasms, Experimental; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Telmisartan; Vascular Endothelial Growth Factor A

2013